CDMO

WuXi STA, a prominent global contract research, development and manufacturing organization (CRDMO), has increased its peptide manufacturing output at its Changzhou campus. Located in southern Jiangsu province in China, Changzhou is part of the Yangtze River Delta region, which is among the most economically developed areas in the country. WuXi STA’s expansion includes two additional…

The boutique contract development and manufacturing organization (CDMO) Wheeler Bio has closed a $31 million Series A financing round, which it plans to use to complete a CGMP cell banking and drug substance manufacturing facility in Oklahoma City. The company specializes in process development and small batch CGMP production of therapeutic antibodies. Wheeler says the…

The contract development and manufacturing organization (CDMO) Scorpion Biological Services will adopt the name Scorpius BioManufacturing after unveiling expanded manufacturing capabilities earlier this year. The company opened a new biomanufacturing facility in San Antonio in October. Scorpius will be headquartered in the same city. A string of companies have also changed their name in 2022. The smoking…

The multinational conglomerate Fujifilm will invest $1.6 billion to improve and ramp up the cell culture manufacturing services of its CDMO subsidiary Fujifilm Diosynth Biotechnologies. Most of the investment will focus on a site in Hillerød, Denmark. A site in College Station, Texas, will also benefit from a funding injection. The investment will increase the…

Recipharm has sold a solid-dose manufacturing plant in Fontaine-lès-Dijon, France to Astrea Pharma, a new contract development and manufacturing organization (CDMO). Recipharm also announced that Pharmaron Beijing Co. has acquired Aesica Pharmaceuticals Ltd, which Recipharm had acquired about a year ago. Historically, the plant in France has focused on manufacturing and packaging tablets and capsules.…